X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare PLETHICO PHARMA with Merck Ltd - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PLETHICO PHARMA vs MERCK LTD - Comparison Results

MERCK LTD 
   Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PLETHICO PHARMA MERCK LTD PLETHICO PHARMA/
MERCK LTD
 
P/E (TTM) x -1.1 34.2 - View Chart
P/BV x 0.0 3.8 0.4% View Chart
Dividend Yield % 0.0 0.7 -  

Financials

 PLETHICO PHARMA   MERCK LTD
EQUITY SHARE DATA
    PLETHICO PHARMA
Mar-14
MERCK LTD
Dec-16
PLETHICO PHARMA/
MERCK LTD
5-Yr Chart
Click to enlarge
High Rs3951,060 37.3%   
Low Rs31623 5.0%   
Sales per share (Unadj.) Rs604.4632.4 95.6%  
Earnings per share (Unadj.) Rs32.545.7 71.0%  
Cash flow per share (Unadj.) Rs51.362.3 82.4%  
Dividends per share (Unadj.) Rs011.00 0.0%  
Dividend yield (eoy) %01.3 0.0%  
Book value per share (Unadj.) Rs473.6388.8 121.8%  
Shares outstanding (eoy) m34.0816.60 205.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.41.3 26.5%   
Avg P/E ratio x6.618.4 35.6%  
P/CF ratio (eoy) x4.213.5 30.7%  
Price / Book Value ratio x0.52.2 20.8%  
Dividend payout %024.1 0.0%   
Avg Mkt Cap Rs m7,26213,969 52.0%   
No. of employees `000NA1.6 0.0%   
Total wages/salary Rs m1,5961,487 107.4%   
Avg. sales/employee Rs ThNM6,631.9-  
Avg. wages/employee Rs ThNM939.2-  
Avg. net profit/employee Rs ThNM479.4-  
INCOME DATA
Net Sales Rs m20,59810,498 196.2%  
Other income Rs m386242 159.4%   
Total revenues Rs m20,98410,741 195.4%   
Gross profit Rs m2,8181,135 248.2%  
Depreciation Rs m642276 233.1%   
Interest Rs m1,5930-   
Profit before tax Rs m9691,102 87.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-138343 -40.3%   
Profit after tax Rs m1,107759 145.9%  
Gross profit margin %13.710.8 126.5%  
Effective tax rate %-14.331.1 -45.9%   
Net profit margin %5.47.2 74.3%  
BALANCE SHEET DATA
Current assets Rs m18,8776,410 294.5%   
Current liabilities Rs m11,8968,828 134.8%   
Net working cap to sales %33.9-23.0 -147.1%  
Current ratio x1.60.7 218.6%  
Inventory Days Days3658 62.3%  
Debtors Days Days19838 515.3%  
Net fixed assets Rs m9,8611,406 701.1%   
Share capital Rs m341166 205.2%   
"Free" reserves Rs m12,3316,286 196.2%   
Net worth Rs m16,1396,455 250.0%   
Long term debt Rs m4,7060-   
Total assets Rs m33,1468,828 375.4%  
Interest coverage x1.6NM-  
Debt to equity ratio x0.30-  
Sales to assets ratio x0.61.2 52.3%   
Return on assets %8.18.6 94.8%  
Return on equity %6.911.8 58.3%  
Return on capital %12.317.1 72.0%  
Exports to sales %21.48.3 258.1%   
Imports to sales %15.221.0 72.3%   
Exports (fob) Rs m4,402869 506.4%   
Imports (cif) Rs m3,1362,209 142.0%   
Fx inflow Rs m4,402959 459.2%   
Fx outflow Rs m3,1842,612 121.9%   
Net fx Rs m1,219-1,653 -73.7%   
CASH FLOW
From Operations Rs m2,4371,070 227.7%  
From Investments Rs m-6,265-750 835.6%  
From Financial Activity Rs m2,490-150 -1,662.3%  
Net Cashflow Rs m-1,337171 -782.4%  

Share Holding

Indian Promoters % 82.7 0.0 -  
Foreign collaborators % 0.0 51.8 -  
Indian inst/Mut Fund % 4.3 18.2 23.6%  
FIIs % 5.5 1.0 550.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 7.5 29.1 25.8%  
Shareholders   10,665 28,591 37.3%  
Pledged promoter(s) holding % 85.7 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PLETHICO PHARMA With:   WOCKHARDT LTD.  J.B.CHEMICALS  ORCHID PHARMA LTD  BIOCON LTD  FULFORD INDIA  

Compare PLETHICO PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Of Global Markets Hitting Record Highs and Top Stocks in Action During the Week(RoundUp)

Global stock markets ended the week on a positive note. Benchmark indices in US grew by 1% during the week. The Down Jones Industrial Average topped the 26,000.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

PLETHICO PHARMA SHARE PRICE


Jun 13, 2016 (Close)

TRACK PLETHICO PHARMA

  • Track your investment in PLETHICO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PLETHICO PHARMA

PLETHICO PHARMA 8-QTR ANALYSIS

COMPARE PLETHICO PHARMA WITH

MARKET STATS